Journal of Breast Imaging最新文献_第8页

Lessons Learned. 经验教训。

IF 2

Journal of Breast Imaging Pub Date : 2024-07-30 DOI: 10.1093/jbi/wbae036

Jay A Baker

引用次数: 0

Pseudocalcifications: Radiologic-Pathologic Correlation of Postsurgical Gauze Artifacts. 假性钙化：手术后纱布伪影的放射学与病理学相关性。

IF 2

Journal of Breast Imaging Pub Date : 2024-07-30 DOI: 10.1093/jbi/wbae018

Daniel Lehrer, Mariela Kaplan, Cecilia Ugalde, Valeria Señuk, Julian Mosto

引用次数: 0

SCOUT® Radar Localization at Time of Breast Biopsy. 乳腺活检时的 SCOUT® 雷达定位。

IF 2

Journal of Breast Imaging Pub Date : 2024-07-30 DOI: 10.1093/jbi/wbae024

Brittany Z Dashevsky, Mohamed S Muneer, Meng Hao, Tie Liang, Irene L Wapnir, Steven P Poplack

{"title":"SCOUT® Radar Localization at Time of Breast Biopsy.","authors":"Brittany Z Dashevsky, Mohamed S Muneer, Meng Hao, Tie Liang, Irene L Wapnir, Steven P Poplack","doi":"10.1093/jbi/wbae024","DOIUrl":"10.1093/jbi/wbae024","url":null,"abstract":"Objective: Evaluate surgical utilization of SCOUT reflectors placed at breast biopsy.Methods: Consent was waived for this retrospective IRB-approved, HIPAA-compliant study. Breast biopsy examinations that reported the term \"SCOUT\" between January 2021 and June 2022 were identified using an institutional search engine. Cases were included if a SCOUT reflector was placed at time of breast biopsy and excluded if lesion pathology was already known. Analysis was performed at the lesion level. A multivariate-regression analysis evaluated 6 variables with potential impact on SCOUT utilization.Results: One hundred twenty-one lesions in 112 patients met inclusion criteria. Biopsy yielded 93% (113/121) malignant, 3% (4/121) elevated risk, 2% (2/121) benign-discordant, and 2% (2/121) benign-concordant results. Two cases lost to follow-up were excluded. SCOUT reflectors were utilized for lumpectomy (58%, 69/119 lesions) and excisional biopsy (6%, 7/119 lesions). SCOUTs were not utilized due to mastectomy (23%, 27/119), subsequent wire localization (2%, 2/119), and nonsurgical cases (12%, 14/119). Reflector placement utilization was 52% higher for findings less than 3.5 cm in size (P <.001), 33% higher in patients without prior treated breast cancer (P = .012), and 19% higher in patients with no suspicious ipsilateral lymph node (P = .048).Conclusion: SCOUT reflector placement at time of biopsy was utilized for surgery 64% (76/119) of the time, although most (98%, 119/121) biopsies were malignant, elevated risk, or benign-discordant. Factors increasing reflector utilization include smaller lesion size, no suspicious ipsilateral lymph node, and no prior treated breast cancer.","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"347-354"},"PeriodicalIF":2.0,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141079618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

2023-2024 Editor's Recognition Awards. 2023-2024 年编辑表彰奖。

IF 2

Journal of Breast Imaging Pub Date : 2024-07-30 DOI: 10.1093/jbi/wbae032

Jay A Baker

引用次数: 0

The FDA Enhancing Quality Using the Inspection Program (EQUIP) Breast Imaging Quality Initiative. 5-Year Clinical Experience. 美国食品药物管理局利用检查计划提高质量（EQUIP）乳腺成像质量计划。5 年临床经验。

IF 2

Journal of Breast Imaging Pub Date : 2024-07-30 DOI: 10.1093/jbi/wbae034

Jeffrey R Hawley, Cynthia Ha, Linda Cai, Clayton R Taylor

{"title":"The FDA Enhancing Quality Using the Inspection Program (EQUIP) Breast Imaging Quality Initiative. 5-Year Clinical Experience.","authors":"Jeffrey R Hawley, Cynthia Ha, Linda Cai, Clayton R Taylor","doi":"10.1093/jbi/wbae034","DOIUrl":"10.1093/jbi/wbae034","url":null,"abstract":"Objectives: To evaluate the effects of the Enhancing Quality Using the Inspection Program (EQUIP) on quality control (QC) and quality assurance (QA) at an academic medical center.Methods: EQUIP audit logs for technologist image quality review as well as mammography unit QA and QC formed the basis for study data. One randomly selected screening mammogram was evaluated by the lead interpreting physician (LIP) using EQUIP criteria for each technologist for each imaging site worked, initially semiannually and then monthly. One randomly selected screening mammogram interpreted by each interpreting physician (IP) for each imaging site was evaluated on a semiannual basis. Quarterly, the LIP reviewed QA and QC logs for each mammography unit with deficiencies further investigated.Results: Of 214 965 eligible screening mammograms performed, 5955 (2.8%) underwent EQUIP image quality review. Five were found to be technically inadequate (0.08%, 5955/214 965). The LIP identified 20 significant interpretive differences compared with the clinical interpretation resulting in 10 biopsies and 7 previously undetected malignancies, with supplemental cancer detection rate of 1.2/1000 cases reviewed. Two hundred ninety mammography unit QA/QC reviews identified 31 potential deficiencies, 29 of which were due to human documentation error (93.4%).Conclusion: EQUIP review of both IP and technologists' quality and mammography unit QA/QC logs as performed identified few deficiencies. EQUIP policies should be evaluated at each institution and modified to best utilize resources and provide opportunities for meaningful quality improvement. Although not an EQUIP focus, supplemental cancer detection was observed as might be expected with double reading.","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"388-396"},"PeriodicalIF":2.0,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unknown Case: Man With a Palpable Retroareolar Mass. 不明病例：可触及乳晕后肿块的男子。

IF 1.5

Journal of Breast Imaging Pub Date : 2024-06-04 DOI: 10.1093/jbi/wbae003

Hieu Diep, Cherie M Kuzmiak

引用次数: 0

Prevalent vs Incident Screen: Why Does It Matter? 普遍筛查与事件筛查：为什么这很重要？

IF 1.5

Journal of Breast Imaging Pub Date : 2024-05-27 DOI: 10.1093/jbi/wbad096

Jessica H Hayward, Amie Y Lee, Edward A Sickles, Kimberly M Ray

引用次数: 0

Breast Hemangiomas: Imaging Features With Histopathology Correlation. 乳腺血管瘤：影像学特征与组织病理学相关性。

IF 1.5

Journal of Breast Imaging Pub Date : 2024-05-27 DOI: 10.1093/jbi/wbae011

Alysha Dhami, Meng Hao, Uzma Waheed, Brittany Z Dashevsky, Gregory R Bean

{"title":"Breast Hemangiomas: Imaging Features With Histopathology Correlation.","authors":"Alysha Dhami, Meng Hao, Uzma Waheed, Brittany Z Dashevsky, Gregory R Bean","doi":"10.1093/jbi/wbae011","DOIUrl":"10.1093/jbi/wbae011","url":null,"abstract":"Breast hemangiomas are rare benign vascular lesions. In a previously performed review of approximately 10,000 breast surgical pathology results, roughly 0.15% (15/~10 000) were hemangiomas. Hemangiomas are more frequent in women and have a documented age distribution of 1.5 to 82 years. They are most often subcutaneous or subdermal and anterior to the anterior mammary fascia but may rarely be seen in the pectoralis muscles or chest wall. On imaging, breast hemangiomas typically present as oval or round masses, often measuring less than 2.5 cm, with circumscribed or mostly circumscribed, focally microlobulated margins, equal or high density on mammography, and variable echogenicity on US. Calcifications, including phleboliths, can be seen. Color Doppler US often shows hypovascularity or avascularity. MRI appearance can vary, although hemangiomas are generally T2 hyperintense and T1 hypointense with variable enhancement. Pathologic findings vary by subtype, which include perilobular, capillary, cavernous, and venous hemangiomas. If core biopsy pathology results are benign, without atypia, and concordant with imaging and clinical findings, surgical excision is not routinely indicated. Because of histopathologic overlap with well-differentiated or low-grade angiosarcomas, surgical excision may be necessary for definitive diagnosis. Findings that are more common with angiosarcomas include size greater than 2 cm, hypervascularity on Doppler US, irregular shape, and invasive growth pattern.","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"288-295"},"PeriodicalIF":1.5,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Atypia Involving Fibroadenomas: Outcomes and Upgrade Rates. 涉及纤维腺瘤的不典型性：结果和升级率

IF 1.5

Journal of Breast Imaging Pub Date : 2024-05-27 DOI: 10.1093/jbi/wbae013

Allison Aripoli, Onalisa Winblad, Christa Balanoff, Jessica Peterson, Camron Smith, Ashley Huppe, Molly Hill, Daniela Wermuth, Nika Gloyeske

{"title":"Atypia Involving Fibroadenomas: Outcomes and Upgrade Rates.","authors":"Allison Aripoli, Onalisa Winblad, Christa Balanoff, Jessica Peterson, Camron Smith, Ashley Huppe, Molly Hill, Daniela Wermuth, Nika Gloyeske","doi":"10.1093/jbi/wbae013","DOIUrl":"10.1093/jbi/wbae013","url":null,"abstract":"Objective: Fibroadenomas (FAs) involved by atypia are rare. Consensus guidelines for management of FAs involved by atypia when diagnosed on image-guided biopsy do not exist because of limited data reporting surgical upgrade rates to ductal carcinoma in situ (DCIS) or invasive malignancy. Therefore, these lesions commonly undergo surgical excision.Methods: This single-institution retrospective study identified cases of FAs involved by atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and/or lobular carcinoma in situ (LCIS) diagnosed on image-guided biopsy between January 2014 and April 2023 to determine upgrade rates. Cases with incidental atypia adjacent to but not involving FAs were excluded.Results: Among 1736 FAs diagnosed on image-guided biopsy, 32 cases (1.8%) were FAs involved by atypia including 43.8% (14/32) ALH, 28.1% (9/32) ADH, 18.8% (6/32) LCIS, 6.3% (2/32) LCIS + ALH, and 3.1% (1/32) unspecified atypia. The most common imaging finding was a mass. Most cases, 81.3% (26/32), underwent subsequent surgical excisional biopsy. A single case of ADH involving and adjacent to an FA was upgraded to FA involved by low-grade DCIS on excision for an overall surgical upgrade rate of 3.8%. There were no cases upgraded to invasive malignancy. For those omitting surgical excision, there was no subsequent malignancy diagnosis at the FA biopsy site over a mean follow-up of 73 months.Conclusion: Cases of radiologic-pathologic concordant FAs involved by atypia have a low upgrade rate of 3.8% and should undergo multidisciplinary review. Larger multi-institutional analysis is needed to determine whether guidelines for excision of atypia should apply to atypia involving FAs.","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"254-260"},"PeriodicalIF":1.5,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140330212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Screening the Implant-Augmented Breast with Digital Breast Tomosynthesis: Is Tomosynthesis Necessary for Non-implant-Displaced Views? 用数字乳腺断层合成技术筛查植入假体的乳房：非植入物移位视图是否需要断层合成？

IF 1.5

Journal of Breast Imaging Pub Date : 2024-05-27 DOI: 10.1093/jbi/wbae021

Derek L Nguyen, Lars J Grimm, Jeffrey S Nelson, Karen S Johnson, Sujata V Ghate

{"title":"Screening the Implant-Augmented Breast with Digital Breast Tomosynthesis: Is Tomosynthesis Necessary for Non-implant-Displaced Views?","authors":"Derek L Nguyen, Lars J Grimm, Jeffrey S Nelson, Karen S Johnson, Sujata V Ghate","doi":"10.1093/jbi/wbae021","DOIUrl":"10.1093/jbi/wbae021","url":null,"abstract":"Objective: To determine cancer visualization utility and radiation dose for non-implant-displaced (ID) views using standard protocol with digital breast tomosynthesis (DBT) vs alternative protocol with 2D only when screening women with implant augmentation.Methods: This retrospective cohort study identified women with implants who underwent screening DBT examinations that had abnormal findings from July 28, 2014, to December 31, 2021. Three fellowship-trained breast radiologists independently reviewed examinations retrospectively to determine if the initially identified abnormalities could be visualized on standard protocol (DBT with synthesized 2D (S2D) for ID and non-ID views) and alternate protocol (DBT with S2D for ID and only the S2D images for non-ID views). Estimated exam average glandular dose (AGD) and associations between cancer visualization with patient and implant characteristics for both protocols were evaluated.Results: The study included 195 patients (mean age 55 years ± 10) with 223 abnormal findings. Subsequent biopsy was performed for 86 abnormalities: 59 (69%) benign, 8 (9%) high risk, and 19 (22%) malignant. There was no significant difference in malignancy visualization rate between standard (19/223, 8.5%) and alternate (18/223, 8.1%) protocols (P = .92), but inclusion of the DBT for non-ID views found one additional malignancy. Total examination AGD using standard protocol (21.9 mGy ± 5.0) was significantly higher than it would be for estimated alternate protocol (12.6 mGy ± 5.0, P <.001). This remained true when stratified by breast thickness: 6.0-7.9 cm, 8.0-9.9 cm, >10.0 cm (all P <.001).Conclusion: The inclusion of DBT for non-ID views did not significantly increase the cancer visualization rate but did significantly increase overall examination AGD.","PeriodicalId":43134,"journal":{"name":"Journal of Breast Imaging","volume":" ","pages":"261-270"},"PeriodicalIF":1.5,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0